Onkologie. 2009:3(2):88-91

Imaging modalities in the diagnostic and treatment of renal cell carcinoma including interventional methods

Martin Mašek1, Petra Holečková2, Jaroslava Dreschlerová1, Martin Horák1,3, Miroslav Kašpar1, Alena Štukavcová1
1 Radiodiagnostická klinika FN Na Bulovce a 1. LF UK Praha
2 Ústav radiační onkologie 1. LF UK a FN na Bulovce, Praha
3 Radiodiagnostická klinika Nemocnice Na Homolce, Praha

Radiology is an integral part of diagnostic, treatment and follow-up of patients with renal cell carcionoma. Radiology with number of

diagnostic method included into management of patients with RCC.

Keywords: ultrasound, CT, MRI, RECIST, radiofrequency ablation, renal cell carcinoma.

Published: April 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Mašek M, Holečková P, Dreschlerová J, Horák M, Kašpar M, Štukavcová A. Imaging modalities in the diagnostic and treatment of renal cell carcinoma including interventional methods. Onkologie. 2009;3(2):88-91.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Levine E, King BF, et al. Adult malignant renal parencyhmal neoplasms. In: Pollack HM, McClennan BL(eds) Clinical urography. Saunders, Philadelphia, 2000; 440-1559.
    2. Siemer S, Uder M, Humke U, et al. Value of ultrasound in early diagnosis of renal cell carcinoma. Urologe 2000; 39: 149-153. Go to original source... Go to PubMed...
    3. Leslie JA, Prihoda T, Thmoson IM. Serendipitous renal cell carcionoma in th post-CT era: continued evidence in improved outcomes. Urol Oncol 2003; 21: 39-44. Go to original source... Go to PubMed...
    4. Smith PA, Marshall FF, Corl FM. et al. Planing nefron-sparing renal surgery using 3D helicac CT angiography. J Comput Assost Tomog 1999; 23: 649-654. Go to original source... Go to PubMed...
    5. Catalano C, Fraioli F, Langhi A, et al. High-resolution multidetektor CT in the preoperative evaluation of the patients with renal cell carcinoma. Am J Roentgenol 2003; 180: 1271-1277. Go to original source... Go to PubMed...
    6. Bellomi M, Petralia G, Sonzogni A, et al. CT perfusion for the monitoring of neoadjuvant chemotherapy and radiation therapy in rectal carcinoma: initial exparience. Radiology 2007; 244: 486-493. Go to original source... Go to PubMed...
    7. Horák M, Ryznarová Z, Kašpar M, et al. Hodnocení účinků chemoterapie u pacientů s osteosarkomem pomocí CT perfuze. Čes. Radiol. 2008; 62(3): 302-308.
    8. Hofer C, Kubler H, hartung R, Breul J, Avril N. Diagnosis and monitoring of urological tumors using positron emision tomography. Eur Urol 2001; 40: 481-487. Go to original source... Go to PubMed...
    9. Krajina A, Peregrin H, et al. Intervenční radiologie - miniinvazivní terapie.Jana Čermáková.1. vydání 2005: 695-700.
    10. Hlava A, Steinhart L, Navrátil P. Intraluminal obliteration of the renal arteries in kidney tumors. Radiology 1976; 121: 323-329. Go to original source... Go to PubMed...
    11. Goldberg SN, Dupuy DE. Image-guided radiofrequency tumor ablation: challenges and opportunities, part I. J Vac Intervert Radiol 2001; 12: 1021-1023. Go to original source... Go to PubMed...
    12. Hořejš J. Radiofrekvenční ablace tumorů jater. In: Krajina A, Peregrin H, et al. Intervenční radiologie - miniinvazivní terapie. Jana Čermáková. 2005; 1. vydání: 727-731.
    13. Gervais DA, McGovern FJ, Arelleno RS, et al. Renal cell carcinoma: clinical experience and technical cucces with radio-frequenci ablation of 42 tumors. Radiology 2003; 226: 417-424. Go to original source... Go to PubMed...

    Return to the content


    Oncology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.